Maki Katherine A, Wallen Gwenyth R, Bastiaanssen Thomaz F S, Hsu Li-Yueh, Valencia Michael E, Ramchandani Vijay A, Schwandt Melanie L, Diazgranados Nancy, Cryan John F, Momenan Reza, Barb Jennifer J
Translational Biobehavioral and Health Disparities Branch, National Institutes of Health, Clinical Center, Bethesda, Maryland, USA.
APC Microbiome Ireland and Department of Anatomy & Neuroscience, University College Cork, Cork, Ireland.
Alcohol Clin Exp Res (Hoboken). 2024 Jul;48(7):1261-1277. doi: 10.1111/acer.15346. Epub 2024 Jun 22.
Alcohol use disorder (AUD) is commonly associated with distressing psychological symptoms. Pathologic changes associated with AUD have been described in both the gut microbiome and brain, but the mechanisms underlying gut-brain signaling in individuals with AUD are unknown. This study examined associations among the gut microbiome, brain morphometry, and clinical symptoms in treatment-seeking individuals with AUD.
We performed a secondary analysis of data collected during inpatient treatment for AUD in subjects who provided gut microbiome samples and had structural brain magnetic resonance imaging (MRI; n = 16). Shotgun metagenomics sequencing was performed, and the morphometry of brain regions of interest was calculated. Clinical symptom severity was quantified using validated instruments. Gut-brain modules (GBMs) used to infer neuroactive signaling potential from the gut microbiome were generated in addition to microbiome features (e.g., alpha diversity and bacterial taxa abundance). Bivariate correlations were performed between MRI and clinical features, microbiome and clinical features, and MRI and microbiome features.
Amygdala volume was significantly associated with alpha diversity and the abundance of several bacteria including taxa classified to Blautia, Ruminococcus, Bacteroides, and Phocaeicola. There were moderate associations between amygdala volume and GBMs, including butyrate synthesis I, glutamate synthesis I, and GABA synthesis I & II, but these relationships were not significant after false discovery rate (FDR) correction. Other bacterial taxa with shared associations to MRI features and clinical symptoms included Escherichia coli and Prevotella copri.
We identified gut microbiome features associated with MRI morphometry and AUD-associated symptom severity. Given the small sample size and bivariate associations performed, these results require confirmation in larger samples and controls to provide meaningful clinical inferences. Nevertheless, these results will inform targeted future research on the role of the gut microbiome in gut-brain communication and how signaling may be altered in patients with AUD.
酒精使用障碍(AUD)通常与令人痛苦的心理症状相关。与AUD相关的病理变化已在肠道微生物群和大脑中得到描述,但AUD患者肠道-大脑信号传导的潜在机制尚不清楚。本研究调查了寻求治疗的AUD患者的肠道微生物群、脑形态测量和临床症状之间的关联。
我们对提供肠道微生物群样本并进行了脑结构磁共振成像(MRI)的AUD住院治疗患者收集的数据进行了二次分析(n = 16)。进行了鸟枪法宏基因组测序,并计算了感兴趣脑区的形态测量值。使用经过验证的工具对临床症状严重程度进行量化。除了微生物群特征(如α多样性和细菌分类群丰度)外,还生成了用于从肠道微生物群推断神经活性信号传导潜力的肠道-大脑模块(GBM)。对MRI与临床特征、微生物群与临床特征以及MRI与微生物群特征之间进行了双变量相关性分析。
杏仁核体积与α多样性以及包括分类为布劳特氏菌属、瘤胃球菌属、拟杆菌属和福卡埃icola属在内的几种细菌的丰度显著相关。杏仁核体积与GBM之间存在中度关联,包括丁酸盐合成I、谷氨酸合成I以及GABA合成I和II,但在错误发现率(FDR)校正后,这些关系并不显著。与MRI特征和临床症状有共同关联的其他细菌分类群包括大肠杆菌和普氏粪杆菌。
我们确定了与MRI形态测量和AUD相关症状严重程度相关的肠道微生物群特征。鉴于样本量较小且进行的是双变量关联分析,这些结果需要在更大的样本和对照中得到证实,以提供有意义的临床推断。尽管如此,这些结果将为未来关于肠道微生物群在肠道-大脑通信中的作用以及AUD患者信号传导可能如何改变的针对性研究提供信息。